4//SEC Filing
GENEREX BIOTECHNOLOGY CORP 4
Accession 0001607062-16-000684
CIK 0001059784operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:03 PM ET
Size
6.7 KB
Accession
0001607062-16-000684
Insider Transaction Report
Form 4
Brusegard David
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2016-02-16$0.00/sh+1,667,671$1,668→ 5,615,070 total - Exercise/Conversion
Common Stock Purchase Option
2016-02-16−1,667,671→ 0 totalExercise: $0.00From: 2016-02-09Exp: 2020-10-26→ Common Stock (1,667,671 underlying)
Documents
Issuer
GENEREX BIOTECHNOLOGY CORP
CIK 0001059784
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001059784
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:03 PM ET
- Size
- 6.7 KB